Jarislowsky, Fraser Ltd’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,349
Closed -$224K 214
2018
Q2
$224K Buy
1,349
+12
+0.9% +$1.93K ﹤0.01% 206
2018
Q1
$225K Sell
1,337
-889
-40% -$149K ﹤0.01% 208
2017
Q4
$364K Buy
2,226
+79
+4% +$14.2K ﹤0.01% 199
2017
Q3
$440K Buy
2,147
+895
+71% +$208K ﹤0.01% 184
2017
Q2
$304K Buy
1,252
+289
+30% +$67.9K ﹤0.01% 185
2017
Q1
$230K Sell
963
-36
-4% -$8.38K ﹤0.01% 191
2016
Q4
$209K Buy
+999
New +$207K ﹤0.01% 193
2015
Q2
Sell
-64,389
Closed -$19.2M 146
2015
Q1
$19.2M Buy
+64,389
New +$18.4M 0.13% 83

Other funds holding AGN

Jarislowsky, Fraser Ltd's AGN Position: Q3 2018 in Review

Jarislowsky, Fraser Ltd sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 1,349 shares — an estimated $224K sold.

Jarislowsky, Fraser Ltd first reported a position in AGN in Q1 2015 and held it in 8 quarters. The position peaked at $19.2M in Q1 2015. 1,066 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Jarislowsky, Fraser Ltd reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Jarislowsky, Fraser Ltd sold 1,349 Allergan plc shares in Q3 2018, an estimated $224K.
  • Jarislowsky, Fraser Ltd first reported a position in Allergan plc in Q1 2015 and held it in 8 quarters.
  • Jarislowsky, Fraser Ltd's Allergan plc position peaked at $19.2M in Q1 2015.
  • 1,066 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2018, filed 14 Nov 2018.